[ad_1] Among patients with atrial fibrillation and dialysis-dependent end stage renal disease, apixaban was badociated with a lower hemorrhagic risk than warfarin, reported the researchers. In a sensitivity badysis, the standard 5 …
Read More »Apixaban may be safer than warfarin in AF, terminal kidney disease
